Jane Street
ANTX icon

Jane Street’s AN2 Therapeutics ANTX Stock Holding History

Jane Street’s Portfolio ANTX Stock Details ANTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-303,649
Closed -$1.04M – 11462
2026
Q1 		$1.04M Buy
303,649
+285,714
+1,593% +$590K ﹤0.01% 6417
2025
Q4 		$20.4K Buy
+17,935
New +$20.9K ﹤0.01% 10722
2025
Q2 		– Sell
-18,131
Closed -$24.7K – 9545
2025
Q1 		$24.7K Buy
+18,131
New +$22.8K ﹤0.01% 9123
2024
Q2 		– Sell
-59,166
Closed -$192K – 9287
2024
Q1 		$192K Sell
59,166
-279
-0.5% -$3.04K ﹤0.01% 8206
2023
Q4 		$1.22M Buy
+59,445
New +$995K ﹤0.01% 5204

Other funds holding ANTX

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Jane Street's ANTX Position: Q2 2026 in Review

Jane Street sold out of AN2 Therapeutics (ANTX) in Q2 2026, closing a stake of 303,649 shares — an estimated $1.04M sold.

Jane Street first reported a position in ANTX in Q4 2023 and held it in 5 quarters. The position peaked at $1.22M in Q4 2023. 66 funds tracked by Wall St. Rank hold ANTX as of Q2 2026.

  • Jane Street reported no remaining AN2 Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 303,649 AN2 Therapeutics shares in Q2 2026, an estimated $1.04M.
  • Jane Street first reported a position in AN2 Therapeutics in Q4 2023 and held it in 5 quarters.
  • Jane Street's AN2 Therapeutics position peaked at $1.22M in Q4 2023.
  • 66 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.